FDA Clarifies Skin Protectant Labeling, Ingredient Combination Options
This article was originally published in The Tan Sheet
Executive Summary
FDA attempts to clarify the active ingredients manufacturers may combine in OTC skin protectant drug products and details corresponding label requirements in draft guidance released Aug. 1
You may also be interested in...
EC Science Committee Gives Qualified OK For 4-MBC In Sunscreens
The European Commission's Scientific Committee on Consumer Products responds to data from the personal care product industry and decides that, at least temporarily, 4-methylbenzylidene camphor is safe in sunscreens at concentrations up to 4 percent
EC Science Committee Gives Qualified OK For 4-MBC In Sunscreens
The European Commission's Scientific Committee on Consumer Products responds to data from the personal care product industry and decides that, at least temporarily, 4-methylbenzylidene camphor is safe in sunscreens at concentrations up to 4 percent
EC Science Committee Gives Qualified OK For 4-MBC In Sunscreens
The European Commission's Scientific Committee on Consumer Products responds to data from the personal care product industry and decides that, at least temporarily, 4-methylbenzylidene camphor is safe in sunscreens at concentrations up to 4 percent